Virus-free and true-to-type: what the claim guarantees

Two claims appear on almost every vitroplant order form: virus-free, and true to type. Both are meaningful. Neither means quite what a quick reading suggests. This is what sits behind each one, step by step, and where each step stops.

Sanitary selection of mother plants

Everything downstream inherits from the mother plant. Selection starts there: healthy, identified stock of a known variety, kept and observed under conditions where a problem would be seen rather than assumed away. A production line built on a poorly chosen mother plant is a production line that multiplies the mistake several thousand times.

What selection rules out: obviously diseased, mislabelled or unverifiable starting material. What it does not rule out: latent infection. Most single-virus infections are asymptomatic. Visual selection alone will pass an infected plant that looks perfect, which is precisely why the next two steps exist.

Meristem culture and thermotherapy

The biology is favourable and worth stating plainly. Viruses travel fast through mature vascular tissue and slowly from cell to cell through plasmodesmata. The apical dome of a shoot tip has no mature vascular tissue, its plasmodesmatal connections are few and gated, and it divides faster than a virus can advance into it. The tip outruns the infection.

So the tip is what we take. A fragment of roughly 0.3–0.5 mm — the dome plus one or two leaf primordia — is excised under a binocular microscope and established on sterile medium. Thermotherapy applied beforehand improves the odds by inhibiting viral replication and restricting movement toward the apex. Combining the two is standard practice for a reason.

What it rules out: the great majority of systemic viral infection carried by the source plant. What it does not rule out: all of it. In a published sweet potato protocol, about 85% of plantlets recovered from 0.3–0.5 mm meristems tested virus-free. A high figure, and not a guarantee. Sanitation is a probability, and it has to be checked.

Viral indexing before production

Indexing is the checking step. Sanitised material is tested for the major viruses of its species before it is allowed to enter production, and the result — not the expectation — decides whether the line goes forward. A line that fails is discarded, not shipped with a caveat.

What indexing rules out: the specific viruses tested for, down to the detection limit of the assay used. What it does not rule out: anything outside that panel. A negative result means "not detected, for these targets, at this sensitivity" — it does not mean "free of every pathogen known to the species". Nor does it protect the plant from reinfection after delivery.

That last point matters commercially. Field trials in sweet potato have shown clean planting material out-yielding farmers’ own material several times over, and have also shown that advantage disappearing after about three successive seasons of on-farm replanting. Clean stock is a renewable input on a cycle, not a permanent state. Anyone selling it as permanent is overselling it.

Lot traceability from initiation to shipment

Each lot is identified and documented from the initiation of the culture through to shipment: source mother plant, sanitation history, indexing results, subculture record, acclimatation batch, delivery. In the EU, plants for planting moving between member states also travel with a plant passport under Regulation (EU) 2016/2031, which carries a traceability code precisely so that a consignment can be traced after the fact.

What traceability rules out: silence. If a batch behaves oddly in the field, the record says which mother plant it came from, which tests it passed, and which other lots share that origin. What it does not rule out: the problem itself. Traceability is how you find and bound a failure. It does not prevent one.

Varietal fidelity

True to type means the delivered plant is genetically the variety you ordered — not a seedling of it, not a drifted selection. Micropropagation through axillary buds is genetically conservative: the bud already exists on the mother plant, and culture conditions simply push it to develop. That route offers the strongest fidelity, and it is how our soft fruit and most horticultural lines are multiplied.

The honest caveat is that not all in-vitro routes are equal. The literature is consistent that long-term callus culture and somatic embryogenesis do not guarantee genetic fidelity, and that somaclonal variation accumulates with the number of subcultures a line has been through. Date palm, multiplied by somatic embryogenesis, sits on the demanding end of that scale.

The controls follow from the biology: capped subculture counts, periodic re-initiation from indexed stock rather than running a line indefinitely, and conformity checks on the output. Fidelity is a managed property of a protocol, not an automatic property of a laboratory.

The GMO question, answered directly

A vitroplant is not a GMO. Genetic modification cuts DNA and inserts sequence that the plant did not have — the genome afterwards is not the genome before. Micropropagation does nothing of the kind. It takes existing tissue and lets it divide, in a jar rather than in soil. Chromosomes and all, the whole plant is copied.

The nearest everyday analogue is a cutting. Taking a cutting is vegetative multiplication; nobody calls a rooted cutting a GMO. In-vitro culture is the same operation performed on a smaller fragment, in sterile conditions, on a defined nutrient medium. The medium supplies sugars, salts and plant hormones — all of which the plant makes or absorbs anyway — and no foreign gene is introduced at any point. There is no vector, no transformation step, no inserted sequence.

Confusion usually comes from the setting: a laboratory, a sterile hood, a jar under lights. The equipment is doing hygiene, not engineering. What the plant is, it stays.

Four delivery formats, and who each one suits

Clean material is only useful if it arrives at the stage your operation can actually take on. Rooting and acclimatation are the fragile transitions, and where they happen determines who carries the risk.

• Non-rooted vitroplant (stage 2) — micro-shoots in flasks, for you to root and acclimate in-house. The most economical and flexible format. For nurseries already equipped with a lab and greenhouse and confident on both transitions.
• Rooted vitroplant (stage 3) — rooted in vitro and ready for acclimatation. Rooting is done; hardening is yours. For nurseries and growers with greenhouse capacity but no lab.
• Acclimated plug (stage 4) — a young plant hardened in a plug, ready to transplant or plant directly. Both fragile transitions are behind it. For growers and farms who want planting stock, not a propagation project.
• Sanitised mother plant — indexed, virus-free stock for your own multiplication programme. You take the clean genetics and run your own scale-up. For breeders and multipliers.

The four formats price differently because they represent different amounts of work already done, and different amounts of risk already absorbed. That is the whole choice.

What the claim comes down to

Virus-free means: sanitised by meristem culture, tested for the major viruses of the species before production, and documented lot by lot. True to type means: multiplied by a route chosen for genetic fidelity, under a protocol that limits the drift it is capable of producing. Both are process claims backed by records, and both stop where the records stop. Stated that way, they are worth more than a stronger claim nobody can check.